CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma
Clinical trial NCT07383233 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07383233
- Sponsor
- Qi deng
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-05-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.